Clinical Trial

Hypoglycemia Thresholds in Type 1 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to compare the impact of hypoglycaemia treatment initiated at a blood glucose threshold of 65 mg/dL versus the internationally recommended threshold of 70 mg/dL on 2-hour post-treatment blood glucose levels and the subsequent development of rebound hyperglycaemia in children with type 1 diabetes. The main questions it aims to answer are: Is there a statistically significant difference in 2-hour post-treatment blood glucose levels in children with type 1 diabetes when hypoglycaemia intervention is initiated at a threshold of 70 mg/dL compared to 65 mg/dL?" In children with type 1 diabetes, does the standard hypoglycaemia treatment initiated at the internationally recommended threshold of 70 mg/dL lead to the development of rebound hyperglycaemia (\<180 mg/dL) at the 2nd hour post-treatment? Patients underwent two protocols: intervention at a 65 mg/dl threshold (hospital routine; experimental group) and 70 mg/dl (literature standard; control group). Both protocols utilised 0.3 g/kg of simple carbohydrates, supplemented with a standardised complex carbohydrate (12.8 g) once blood glucose exceeded the target.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-14.
Trial Details
NCT Number NCT07711275
Lead Sponsor Marmara University
Conditions Diabetes Mellitus, Type 1
Enrollment 33 participants
Start Date 2024-12-01
Primary Completion 2025-02-25 (estimated)
Study Completion 2025-02-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-20